3-139005853-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001134659.1(PRR23A):c.416A>T(p.Gln139Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001134659.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRR23A | NM_001134659.1 | c.416A>T | p.Gln139Leu | missense_variant | 1/1 | ENST00000383163.4 | NP_001128131.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRR23A | ENST00000383163.4 | c.416A>T | p.Gln139Leu | missense_variant | 1/1 | 6 | NM_001134659.1 | ENSP00000372649.2 | ||
MRPS22 | ENST00000495075 | c.-385T>A | 5_prime_UTR_variant | 1/10 | 1 | ENSP00000418008.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152056Hom.: 0 Cov.: 31 FAILED QC
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461720Hom.: 0 Cov.: 56 AF XY: 0.00 AC XY: 0AN XY: 727136
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152056Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.416A>T (p.Q139L) alteration is located in exon 1 (coding exon 1) of the PRR23A gene. This alteration results from a A to T substitution at nucleotide position 416, causing the glutamine (Q) at amino acid position 139 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at